Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuma Tokunaga

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Cancer Treatment Reviews|December 15, 2018
B cell and B cell-related pathways for novel cancer treatmentsRyuma Tokunaga, Madiha Naseem, Jae Ho Lo, et al.
Oncology Reports|December 17, 2013
Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cellsShigeki Nakagawa, Yasuo Sakamoto, Hirohisa Okabe, et al.
Journal of Cancer Metastasis and Treatment|September 17, 2021
Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectivesFrancesca Battaglin, Alberto Puccini, Madiha Naseem, et al.
Annals of Surgical Oncology|January 8, 2015
Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal CancerYuji Miyamoto, Yoshifumi Baba, Yasuo Sakamoto, et al.
Annals of Surgical Oncology|June 27, 2020
Total Lesion Glycolysis Ratio in Positron Emission Tomography/Computed Tomography Images During Neoadjuvant Chemotherapy Can Predict Pathological Tumor Regression Grade and Prognosis in Patients with Locally Advanced Squamous Cell Carcinoma of the EsophagusAkari Sonoda, Naoya Yoshida, Shinya Shiraishi, et al.
International Journal of Clinical Oncology|June 4, 2016
Risk factors of early recurrence within 6 months after esophagectomy following neoadjuvant chemotherapy for resectable advanced esophageal squamous cell carcinomaNaoya Yoshida, Yoshifumi Baba, Hironobu Shigaki, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 24, 2017
Colorectal cancer: epigenetic alterations and their clinical implicationsAlberto Puccini, Martin D Berger, Madiha Naseem, et al.
Cancer Treatment Reviews|April 10, 2018
Outlooks on Epstein-Barr virus associated gastric cancerMadiha Naseem, Afsaneh Barzi, Christine Brezden-Masley, et al.
Journal of Cancer Research and Clinical Oncology|April 14, 2023
The colon inflammatory index score can predict the survival outcome after resection of colorectal cancer: a retrospective multicentre studyTakahiko Akiyama, Yuji Miyamoto, Akihisa Matsuda, et al.
International Journal of Colorectal Disease|October 12, 2016
CONUT: a novel independent predictive score for colorectal cancer patients undergoing potentially curative resectionRyuma Tokunaga, Yasuo Sakamoto, Shigeki Nakagawa, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Cancer Treatment Reviews|December 15, 2018
B cell and B cell-related pathways for novel cancer treatmentsRyuma Tokunaga, Madiha Naseem, Jae Ho Lo, et al.
Oncology Reports|December 17, 2013
Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cellsShigeki Nakagawa, Yasuo Sakamoto, Hirohisa Okabe, et al.
Journal of Cancer Metastasis and Treatment|September 17, 2021
Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectivesFrancesca Battaglin, Alberto Puccini, Madiha Naseem, et al.
Annals of Surgical Oncology|January 8, 2015
Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal CancerYuji Miyamoto, Yoshifumi Baba, Yasuo Sakamoto, et al.
Annals of Surgical Oncology|June 27, 2020
Total Lesion Glycolysis Ratio in Positron Emission Tomography/Computed Tomography Images During Neoadjuvant Chemotherapy Can Predict Pathological Tumor Regression Grade and Prognosis in Patients with Locally Advanced Squamous Cell Carcinoma of the EsophagusAkari Sonoda, Naoya Yoshida, Shinya Shiraishi, et al.
International Journal of Clinical Oncology|June 4, 2016
Risk factors of early recurrence within 6 months after esophagectomy following neoadjuvant chemotherapy for resectable advanced esophageal squamous cell carcinomaNaoya Yoshida, Yoshifumi Baba, Hironobu Shigaki, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 24, 2017
Colorectal cancer: epigenetic alterations and their clinical implicationsAlberto Puccini, Martin D Berger, Madiha Naseem, et al.
Cancer Treatment Reviews|April 10, 2018
Outlooks on Epstein-Barr virus associated gastric cancerMadiha Naseem, Afsaneh Barzi, Christine Brezden-Masley, et al.
Journal of Cancer Research and Clinical Oncology|April 14, 2023
The colon inflammatory index score can predict the survival outcome after resection of colorectal cancer: a retrospective multicentre studyTakahiko Akiyama, Yuji Miyamoto, Akihisa Matsuda, et al.
International Journal of Colorectal Disease|October 12, 2016
CONUT: a novel independent predictive score for colorectal cancer patients undergoing potentially curative resectionRyuma Tokunaga, Yasuo Sakamoto, Shigeki Nakagawa, et al.
Pageof 8